INVO Fertility (IVF) Return on Capital Employed Growth (5y) (2017 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | INVO Fertility | 5.12 Mn | 4.76 Mn | 629,345.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 370,762.00 |
| Jun 30, 2025 | 3.52 Mn |
| Mar 31, 2025 | -60,433.00 |
| Dec 31, 2024 | 24,567.00 |
| Sep 30, 2024 | 39,443.00 |
| Jun 30, 2024 | 16,836.00 |
| Mar 31, 2024 | -131,032.00 |
| Dec 31, 2023 | -16,855.00 |
| Sep 30, 2023 | -4,660.00 |
| Jun 30, 2023 | 498.00 |
| Mar 31, 2023 | 5,218.00 |
| Dec 31, 2022 | -35,219.00 |
| Sep 30, 2022 | -11,530.00 |
| Jun 30, 2022 | -7,330.00 |
| Mar 31, 2022 | -7,742.00 |
| Dec 31, 2021 | -6,529.00 |
| Sep 30, 2021 | -16,414.00 |
| Jun 30, 2021 | -12,802.00 |
| Mar 31, 2021 | -8,161.00 |
| Dec 31, 2020 | -15,192.00 |
| Sep 30, 2020 | -394,087.00 |
| Jun 30, 2020 | -3.54 Mn |
| Mar 31, 2020 | 48,029.00 |
| Dec 31, 2019 | -30,186.00 |
| Sep 30, 2019 | -20,849.00 |
| Jun 30, 2019 | -10,871.00 |
| Mar 31, 2019 | 5,047.00 |
| Dec 31, 2018 | 8,344.00 |
| Sep 30, 2018 | 3,857.00 |
| Jun 30, 2018 | 3,518.00 |
| Mar 31, 2018 | -465.00 |
| Dec 31, 2017 | -332.00 |
| Sep 30, 2017 | -260.00 |
| Jun 30, 2017 | -252.00 |
| Mar 31, 2017 | 2,504.00 |